Arcadia Q2 net loss $6.3M; cash burn only $319K, Zola July sales $740K

Arcadia Biosciences, Inc.

Q2 net loss $6.3M ($2.09/share) vs $4.5M loss a year ago; revenue $1.44M, down 1% YoY.
Cash used in ops only $319K in Q2; cash balance $4.2M after $4M June private placement.
Zola July sales topped $740K, exceeding $1M through first week of August; Q2 sales flat due to inventory/shipping issues.
SG&A down $1.0M YoY to all-time low; Q4 2026 launch of 1-liter espresso with pre-launch commitments from two largest customers.
First half net loss $10.7M ($4.19/share) vs $1.9M loss; includes $5.4M valuation loss on June PIPE and $4.3M unrealized loss on Above Food stock.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.